key: cord-1042678-nrojme77
authors: Kalemci, Serdar; Sarıhan, Aydın; Zeybek, Arife; Kargı, Ahmet Bülent
title: Acute pulmonary embolism in COVID-19 disease
date: 2020-11-15
journal: Int J Cardiol
DOI: 10.1016/j.ijcard.2020.06.063
sha: 9dc9913b1ac0ad9f8909252b9e21c728fdacb23b
doc_id: 1042678
cord_uid: nrojme77

nan

We read with great interest the article recently published by Faggiano et al. entitled "Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients." [1] . In this study, the authors have compared the parameters such as age, sex, comorbidities, laboratory findings, use of anticoagulants and radiological findings in Covid-19 patients with and without acute pulmonary embolism. It has been emphasized that increased levels of D-dimer, worsening in clinical symptoms and abnormal blood levels during the follow-up should alert the clinician. Active smoking is known as a major risk factor in venous thromboembolism [2] . In addition, it has been shown that obesity increases the risk of venous thromboembolism [3] . In this study, we did not seen any information about smoking and obesity status of the patients. We believe that these factors may greatly affect the results of the study.

Aresearch concept and design; Serdar Kalemci, Nihat Tasdemir. Bwriting the article; Serdar Kalemci, Aydın Sarıhan, Ahmet Bülent Kargı.

Ccritical revision of the article; Serdar Kalemci, Arife Zeybek, Ahmet Bülent Kargı.

Acute pulmonary embolism in COVID-19 disease: preliminary report on seven patients

Cardiovascular risk factors associated with venous thromboembolism

The epidemiology of venous thromboembolism